(Q34095782)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20824010%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

The Oral Serine Protease Inhibitor WX-671 - First Experience in Patients with Advanced Head and Neck Carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20824010%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20824010%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Jens E Meyer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20824010%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Carsten Brocks

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20824010%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Hendrik Graefe

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20824010%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Carola Mala

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20824010%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Natalie Thäns

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20824010%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Markus Bürgle

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20824010%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Annette Rempel

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20824010%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Barbara Wollenberg

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20824010%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Stephan Lang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20824010%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

16 October 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20824010%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20824010%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20824010%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

s2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20824010%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

20-24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20824010%20AND%20SRC:MED&resulttype=core&format=json

Inhibition of the invasion capacity of carcinoma cells by WX-UK1, a novel synthetic inhibitor of the urokinase-type plasminogen activator system

13 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930998

Clinical and epidemiological data of patients with malignomas of the head and neck

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930998

Interference with the urokinase plasminogen activator system: a promising therapy concept for solid tumours

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930998

Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930998

The plasminogen activation system in tumor growth, invasion, and metastasis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930998

Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930998

Immunohistochemical localization of a urokinase-type plasminogen activator system in squamous cell carcinoma of the oral cavity: association with mode of invasion and lymph node metastasis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930998

Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930998

Inhibition of invasion and metastasis in oral cancer by targeting urokinase-type plasminogen activator receptor.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930998

Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary report

28 October 2018

1 reference

12 December 2020

Urokinase receptor up-regulation in head and neck squamous cell carcinoma

1 reference

12 December 2020

Impaired wound healing in mice with a disrupted plasminogen gene

1 reference

12 December 2020

Gene targeting and gene transfer studies of the biological role of the plasminogen/plasmin system

1 reference

12 December 2020

Tumour-associated proteolytic factors uPA and PAI-1 and survival in totally resected gastric cancer

1 reference

12 December 2020

Urokinase-type plasminogen activator antigen and early relapse in breast cancer

1 reference

12 December 2020

Clinical relevance of urokinase plasminogen activator, its receptor, and its inhibitor in patients with renal cell carcinoma

1 reference

12 December 2020

1 reference

12 December 2020

Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis (review)

1 reference

12 December 2020

Urokinase-type plasminogen activator, plasminogen activator inhibitor type 1 and cathepsin D: analysis of their prognostic significance in squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) in tissue and serum of head and neck squamous cell carcinoma patients

1 reference

12 December 2020

Identifiers

DOI

10.1159/000151736

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20824010%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20824010%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

PubMed publication ID

20824010

1 reference